Amwill Healthcare IPO - Day 3 Subscription at 1.78 Times

Amwill Healthcare's initial public offering (IPO) has received moderate investor interest over the three-day period. The IPO witnessed steady growth in demand, with subscription rates progressing from 1.04 times on day one, to 1.42 times on day two, and reaching 1.78 times by 11:19 AM on the final day.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Amwill Healthcare IPO, which opened on February 5, 2025, has seen mixed participation across categories. The Retail Investors segment has shown good interest, reaching 2.53 times subscription, while QIB portion achieved 2.19 times subscription. The NII segment registered 0.82 times subscription.

Subscription Status of Amwill Healthcare IPO:

Here are the subscription details for Amwill Healthcare IPO as of Day 3 (February 7, 2025, 11:19 AM):

Note:

• "Shares Offered" and "Total Amount" are calculated based on the upper price band of ₹111
• The portion of market maker is not included in the total shares offered

Key Highlights - Day 3:

• Overall subscription reached 1.78 times on the final day
• Retail investors showing good interest at 2.53 times subscription
• QIB portion maintained at 2.19 times subscription
• NII segment improved to 0.82 times
• Total bids worth ₹101.39 crores received
• Applications reached 5,167 showing moderate retail interest
• Market response indicating steady demand
• Most categories showing oversubscription

Amwill Healthcare IPO - Day 2 Subscription at 1.42 Times

Key Highlights - Day 2:

• Overall subscription grew to 1.42 times
• Retail investors showed growth to 1.92 times
• QIB portion stable at 2.19 times
• NII segment slightly improved to 0.53 times
• Day two witnessed moderate momentum
• Market response showing steady progress
• Consistent participation across segments
• Retail interest building up

Amwill Healthcare IPO - Day 1 Subscription at 1.04 Times

Key Highlights - Day 1

• Overall subscription opened at 1.04 times
• Retail investors began at 1.00 times
• QIB portion started strong at 2.19 times
• NII segment showed initial interest at 0.51 times
• Opening day showed balanced response
• Initial momentum indicating steady interest
• QIB segment demonstrating confidence
• Moderate retail participation from start

About Amwill Healthcare 

Amwill Healthcare Limited, established in August 2017, has emerged as a specialized player in the derma-cosmetic development sector. The company operates through a strategic asset-light business model, partnering with contract manufacturers, distributors, and third-party product development agencies to enhance its manufacturing, packaging, and distribution capabilities. With a focus on both generic dermatological solutions and targeted treatments, the company has built a comprehensive portfolio addressing various skin conditions including acne, fungal infections, anti-aging, and other dermatological issues.

The company's financial performance demonstrates impressive growth with revenue increasing from ₹30.28 crores in FY2023 to ₹44.28 crores in FY2024, while profit after tax rose significantly from ₹3.11 crores to ₹12.54 crores. For the six months ended September 30, 2024, the company reported revenue of ₹23.25 crores with a strong PAT of ₹6.52 crores, showcasing robust operational efficiency and profitability.

Their competitive strengths include:

• Extensive dermatological product portfolio
• Strong product formulation capabilities
• Quality-focused development through strategic partnerships
• Experienced management team
• Asset-light business model
• Robust distribution network in South India
• Focus on research and development
   

Highlights of the Amwill Healthcare IPO:

• IPO type: Book Built Issue SME IPO
• IPO size: ₹59.98 crores
• Fresh Issue: ₹48.88 crores
• Offer for Sale: ₹11.10 crores
• Face value: ₹10 per share
• Price band: ₹105 to ₹111 per share
• Lot size: 1,200 shares
• Minimum investment for retail investors: ₹1,33,200
• Minimum investment for HNI: ₹2,66,400 (2 lots)
• Market maker reservation: 2,71,200 shares
• Listing at: BSE SME
• IPO opens: February 5, 2025
• IPO closes: February 7, 2025
• Allotment date: February 10, 2025
• Refund initiation: February 11, 2025
• Credit of shares: February 11, 2025
• Listing date: February 12, 2025
• Lead Manager: Unistone Capital Pvt Ltd
• Registrar: Bigshare Services Pvt Ltd
• Market Maker: Globalworth Securities Limited